All coverage
Amprius Technologies — the silicon‑anode battery maker behind some of the highest‑energy lithium‑ion cells in the industry — is back on traders’ radar today,…
Lockheed Martin heads into Tuesday’s session under pressure, even as its fundamentals look solid on paper. As of late Monday trading, Lockheed Martin shares…
New York — November 25, 2025 — Axsome Therapeutics heads into Tuesday’s session trading just below fresh record highs, powered by blockbuster growth from…
Altimmune Inc. continues its November rebound. As of early trading on Tuesday, November 25, ALT is changing hands around $5.1 per share, roughly flat…
After one of the sharpest pullbacks in its multi‑year rally, German defence group Rheinmetall AG enters Tuesday’s session under close watch. The stock is…
Shares of Sarepta Therapeutics head into Tuesday’s session trying to build on a rare rally, as investors digest a positive safety update for its…
Rumble Inc. heads into Tuesday’s session on the back of one of its strongest two-day moves of 2025, fueled by fresh commitments from crypto…
As of Monday’s close on November 24, NUAI finished at $4.40, up about 15.8% on the day, with roughly 8.6 million shares traded on…
Kohl’s Corporation heads into a high‑stakes trading day on Tuesday, November 25, 2025, with a fresh CEO, an earnings report due, and the holiday…
Dell Technologies stock is back under the spotlight today as investors brace for the company’s third‑quarter fiscal 2026 earnings report after the closing bell.…
As traders log in on Tuesday, November 25, 2025, Plus Therapeutics is back on the radar thanks to a cluster of late‑November catalysts: an…
Viking Therapeutics heads into the Tuesday, November 25, 2025 session trading in the mid‑$30s, still digesting last week’s major milestone: the company has finished…
Diginex Limited has become one of 2025’s wildest small-cap stories. The ESG and sustainability RegTech firm has seen its DGNX stock rocket more than…
As investors head into the Tuesday, November 25 session, Pfizer Inc. remains one of Wall Street’s most closely watched healthcare names. After a brutal…
Shares of the small-cap biotech closed around $14.29 on November 25, 2025, down roughly 11% on the session, putting the stock well below its…
Baidu’s U.S.-listed shares rallied sharply on Monday, November 25, 2025, as investors digested fresh analyst upgrades and continued to reposition around the Chinese search…
